ERBB2 and neoplasm: MD.45-HER/ζ cells did not exhibit any therapeutic effect when mice were inoculated with ALC or FM3 tumour cells not expressing HER-2/neu (i.e., ALC-mock or FM3-mock cells) indicating the specificity of the in vivo antitumour response.